Matthew L. Trerotola Enovis Corp (ENOV) insider trading activity

Matthew L. Trerotola is CEO of Enovis CORP. Currently has a direct ownership of 270,074 shares of ENOV, which is worth approximately $11.2 Million. The most recent transaction as insider was on Jul 19, 2021, when has been sold 75,000 shares (Common stock, par value $.001) at a price of $42.89 per share, resulting in proceeds of $3,216,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 270K

0% 3M change

36.82% 12M change

Total Value Held $11.2 Million

Matthew L. Trerotola Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 19 2021	SELL Open market or private sale	$3,216,750 $42.89 p/Share	75,000 Reduced 19.7%	305,708 Common stock, par valu...
Jul 19 2021	BUY Exercise of conversion of derivative security	$1,780,500 $23.74 p/Share	75,000 Added 16.46%	380,708 Common stock, par valu...
Jun 21 2021	SELL Open market or private sale	$3,330,750 $44.41 p/Share	75,000 Reduced 19.7%	305,708 Common stock, par valu...
Jun 21 2021	BUY Exercise of conversion of derivative security	$1,780,500 $23.74 p/Share	75,000 Added 16.46%	380,708 Common stock, par valu...
May 14 2021	SELL Open market or private sale	$8,628,000 $43.14 p/Share	200,000 Reduced 39.55%	305,708 Common stock, par valu...
May 14 2021	BUY Exercise of conversion of derivative security	$4,748,000 $23.74 p/Share	200,000 Added 28.34%	505,708 Common stock, par valu...
Mar 05 2021	BUY Grant, award, or other acquisition	-	72,009 Added 19.06%	305,708 Common stock, par valu...
Feb 25 2021	SELL Open market or private sale	$278,683 $46.01 p/Share	6,057 Reduced 2.53%	233,699 Common stock, par valu...
Feb 22 2021	BUY Grant, award, or other acquisition	-	38,789 Added 13.93%	239,756 Common stock, par valu...
Jan 05 2021	SELL Open market or private sale	$844,094 $38.3 p/Share	22,039 Reduced 9.88%	200,967 Common stock, par valu...

Also insider at

ATR

APTARGROUP, INC. Healthcare

Director

MLT